Medicamen Biotech Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 465.02 million compared to INR 355.82 million a year ago. Revenue was INR 473.33 million compared to INR 362.11 million a year ago. Net income was INR 20.3 million compared to INR 37.65 million a year ago. Basic earnings per share from continuing operations was INR 1.6 compared to INR 2.98 a year ago. Diluted earnings per share from continuing operations was INR 1.6 compared to INR 2.98 a year ago.
For the nine months, sales was INR 1,319.87 million compared to INR 1,022.02 million a year ago. Revenue was INR 1,337.46 million compared to INR 1,043.18 million a year ago. Net income was INR 88.03 million compared to INR 109.54 million a year ago. Basic earnings per share from continuing operations was INR 5.89 compared to INR 8.66 a year ago. Diluted earnings per share from continuing operations was INR 5.89 compared to INR 8.66 a year ago.